Prediction and establishment of a new crystalline piroxicam modification.
The existence of a new crystalline modification of the analgesic and antiinflammatory agent piroxicam was predicted. A model of the structure was derived from the crystal data of the alpha-modification. Lattice constants and molecular packing parameters were refined using X-ray powder diffraction data.